Detalhe da pesquisa
1.
Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting.
Eur J Nucl Med Mol Imaging
; 44(2): 332-341, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27900520
2.
Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands.
Br J Haematol
; 175(4): 661-667, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27605358
3.
Combination therapy with bortezomib, continuous low-dose cyclophosphamide and dexamethasone followed by one year of maintenance treatment for relapsed multiple myeloma patients.
Br J Haematol
; 171(5): 720-5, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26358087
4.
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.
EClinicalMedicine
; 63: 102167, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680948
5.
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.
J Clin Oncol
; 39(25): 2758-2767, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945289
6.
Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.
Rheumatology (Oxford)
; 50(10): 1925-6, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21719421
7.
18F-FDG PET increases visibility of bone lesions in relapsed multiple myeloma: is this hypoxia-driven?
Clin Nucl Med
; 40(4): 291-6, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25546223
8.
Is FDG PET a better imaging tool than somatostatin receptor scintigraphy in patients with relapsing multiple myeloma?
Clin Nucl Med
; 37(10): 939-42, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22955067